{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:49:54Z","timestamp":1768038594253,"version":"3.49.0"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.thromres.2023.10.001","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T11:50:30Z","timestamp":1696593030000},"page":"99-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Treatment of congenital coagulopathies, from biologic to biotechnological drugs: The relevance of gene editing (CRISPR\/Cas)"],"prefix":"10.1016","volume":"231","author":[{"given":"Juan A.","family":"De Pablo-Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Miguel-Batuecas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Carlos","family":"Rodr\u00edguez-Merch\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Liras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2023.10.001_bb0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/physrev.00016.2011","article-title":"New Fundamentals in Hemostasis","volume":"93","author":"Versteeg","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.thromres.2023.10.001_bb0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4997\/JRCPE.2014.110","article-title":"Coagulation","volume":"44","author":"Chee","year":"2014","journal-title":"J. R. Coll. Physicians Edinb."},{"key":"10.1016\/j.thromres.2023.10.001_bb0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/labmed\/lmx050","article-title":"Coagulation Testing in the Core Laboratory","volume":"48","author":"Winter","year":"2017","journal-title":"Lab. Med."},{"key":"10.1016\/j.thromres.2023.10.001_bb0020","first-page":"259","article-title":"Factor V Leiden","volume":"90","author":"Applegate","year":"2019","journal-title":"Radiol. Technol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0025","first-page":"371","article-title":"Clinical efficacy of fresh frozen plasma compared with coagulation factor concentrates for treating coagulopathy in patients with massive bleeding","volume":"40","author":"Kozek-Langenecker","year":"2016","journal-title":"Med. Int."},{"key":"10.1016\/j.thromres.2023.10.001_bb0030","doi-asserted-by":"crossref","first-page":"7647","DOI":"10.3390\/ijms22147647","article-title":"Gene Therapy in Hemophilia: Recent Advances","volume":"22","author":"Rodr\u00edguez-Merch\u00e1n","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.thromres.2023.10.001_bb0035","doi-asserted-by":"crossref","first-page":"eabj6901","DOI":"10.1126\/sciadv.abj6901","article-title":"In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy","volume":"8","author":"Han","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.thromres.2023.10.001_bb0040","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.3390\/ijms23105802","article-title":"Development and Characterization of a Factor V-Deficient CRISPR Cell Model for the Correction of Mutations","volume":"23","author":"Serrano","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.thromres.2023.10.001_bb0045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4103\/0019-5049.144643","article-title":"Overview of the coagulation system","volume":"58","author":"Palta","year":"2014","journal-title":"Indian J. Anaesth."},{"key":"10.1016\/j.thromres.2023.10.001_bb0050","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1515\/cclm-2017-1205","article-title":"Laboratory hemostasis: from biology to the bench","volume":"56","author":"Lippi","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.thromres.2023.10.001_bb0055","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.2174\/0929867043364603","article-title":"The Hemostatic System","volume":"11","author":"Stassen","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.thromres.2023.10.001_bb0060","first-page":"319","article-title":"Mechanism Action of Platelets and Crucial Blood Coagulation Pathways in Hemostasis","volume":"11","author":"Periayah","year":"2017","journal-title":"Int. J. Hematol. Oncol. Stem Cell Res."},{"key":"10.1016\/j.thromres.2023.10.001_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0029-1214144","article-title":"Milestones and Perspectives in Coagulation and Hemostasis","volume":"35","author":"Lippi","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2023.10.001_bb0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev."},{"key":"10.1016\/j.thromres.2023.10.001_bb0075","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.earlhumdev.2015.08.009","article-title":"Congenital and acquired bleeding disorders in infancy","volume":"91","author":"Campbell","year":"2015","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.thromres.2023.10.001_bb0080","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1182\/asheducation-2016.1.232","article-title":"Congenital and acquired bleeding disorders in pregnancy","volume":"2016","author":"Gernsheimer","year":"2016","journal-title":"Hematology Am. Soc. Hematol. Educ. Program."},{"key":"10.1016\/j.thromres.2023.10.001_bb0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-021-00278-x","article-title":"Haemophilia","volume":"7","author":"Berntorp","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.thromres.2023.10.001_bb0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.18388\/abp.2015_1056","article-title":"The factor VIII protein and its function","volume":"63","author":"Mazurkiewicz-Pisarek","year":"2016","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0095","series-title":"Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and other Body Fluid Proteins. Subcellular Biochemistry","first-page":"437","article-title":"Physiological Roles of the von Willebrand Factor-Factor VIII Interaction","volume":"94","author":"Kiouptsi","year":"2020"},{"key":"10.1016\/j.thromres.2023.10.001_bb0100","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1182\/blood.2020007562","article-title":"Activated protein C has a regulatory role in factor VIII function","volume":"137","author":"Wilhelm","year":"2021","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.10.001_bb0105","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619888293","article-title":"Identification of the Intron 22 and Intron 1 Inversions of the Factor VIII Gene in Iraqi Kurdish Patients With Hemophilia A","volume":"26","author":"Abdulqader","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2023.10.001_bb0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3324\/haematol.2017.186353","article-title":"Hemophilia A: different phenotypes may be explained by multiple and variable effects of the causative mutation in the F8 gene","volume":"103","author":"Castaman","year":"2018","journal-title":"Haematologica."},{"key":"10.1016\/j.thromres.2023.10.001_bb0115","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1111\/jth.14315","article-title":"The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTH","volume":"16","author":"Makris","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.001_bb0120","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1111\/j.1365-2516.2010.02379.x","article-title":"Radioactive synovectomy with Yttrium90 citrate in haemophilic synovitis: Brazilian experience","volume":"17","author":"Thomas","year":"2011","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2023.10.001_bb0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MBC.0000000000000803","article-title":"Accelerating recovery from acute hemarthrosis in patients with hemophilia: the role of joint aspiration","volume":"30","author":"De la Corte-Rodriguez","year":"2019","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2023.10.001_bb0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(15)01123-X","article-title":"The past and future of haemophilia: diagnosis, treatments, and its complications","volume":"388","author":"Peyvandi","year":"2016","journal-title":"Lancet."},{"issue":"Suppl. 4","key":"10.1016\/j.thromres.2023.10.001_bb0135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2516.2012.02841.x","article-title":"Rare bleeding disorders","volume":"18","author":"Peyvandi","year":"2012","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2023.10.001_bb0140","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0140-6736(03)13405-8","article-title":"Haemophilias A and B","volume":"361","author":"Bolton-Maggs","year":"2003","journal-title":"Lancet."},{"key":"10.1016\/j.thromres.2023.10.001_bb0145","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.transci.2018.10.009","article-title":"Management of rare coagulation disorders in 2018","volume":"57","author":"Jain","year":"2018","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.thromres.2023.10.001_bb0150","series-title":"Review, Pediatr. Rev","first-page":"289","article-title":"Hemophilia","volume":"34","author":"Zimmerman","year":"2013"},{"key":"10.1016\/j.thromres.2023.10.001_bb0155","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/hae.13804","article-title":"Phenotypic characterization of haemophilia B \u2013 Understanding the underlying biology of coagulation factor IX","volume":"25","author":"Tj\u00e4rnlund-Wolf","year":"2019","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2023.10.001_bb0160","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3324\/haematol.2019.221093","article-title":"Hemophilia A and B: molecular and clinical similarities and differences","volume":"104","author":"Castaman","year":"2019","journal-title":"Haematologica."},{"key":"10.1016\/j.thromres.2023.10.001_bb0165","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.3390\/ijms23052762","article-title":"The Molecular Basis of FIX Deficiency in Hemophilia B","volume":"23","author":"Shen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.thromres.2023.10.001_bb0170","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1538-7836.2008.03001.x","article-title":"Validation of a composite score for clinical severity of hemophilia","volume":"6","author":"Schulman","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.001_bb0175","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/hae.12133","article-title":"Is haemophilia B less severe than haemophilia A?","volume":"19","author":"Mannucci","year":"2013","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2023.10.001_bb0180","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/a-1945-9429","article-title":"Insights into the Molecular Genetic of Hemophilia A and Hemophilia B: The Relevance of Genetic Testing in Routine Clinical Practice","volume":"42","author":"Pezeshkpoor","year":"2022","journal-title":"Hamostaseologie."},{"key":"10.1016\/j.thromres.2023.10.001_bb0185","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/jth.12958","article-title":"Hemophilia B: molecular pathogenesis and mutation analysis","volume":"13","author":"Goodeve","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.001_bb0190","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-0039-1687906","article-title":"A Comprehensive Overview of Coagulation Factor V and Congenital Factor V Deficiency","volume":"45","author":"Tabibian","year":"2019","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2023.10.001_bb0195","doi-asserted-by":"crossref","first-page":"9705","DOI":"10.3390\/ijms22189705","article-title":"Future Perspectives for Factor V Deficiency Using Recombinant and Advanced Therapies","volume":"22","author":"Bernal","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.thromres.2023.10.001_bb0200","series-title":"Congenital Bleeding Disorders","first-page":"201","article-title":"Congenital Factor V Deficiency","author":"Tabibian","year":"2018"},{"key":"10.1016\/j.thromres.2023.10.001_bb0205","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.3390\/ijms23158283","article-title":"The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V","volume":"23","author":"De Pablo-Moreno","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.thromres.2023.10.001_bb0210","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1021\/bi00130a007","article-title":"Structure of the gene for human coagulation factor V","volume":"31","author":"Cripe","year":"1992","journal-title":"Biochemistry."},{"key":"10.1016\/j.thromres.2023.10.001_bb0215","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1538-7836.2007.02810.x","article-title":"Defining the structure of membrane-bound human blood coagulation factor Va","volume":"6","author":"Stoilova-Mcphie","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.001_bb0220","doi-asserted-by":"crossref","first-page":"gzaa029","DOI":"10.1093\/protein\/gzaa029","article-title":"Construction, characterization and crystal structure of a fluorescent single-chain Fv chimera","volume":"34","author":"Velappan","year":"2021","journal-title":"Protein Engineering, Protein Eng. Des. Sel."},{"key":"10.1016\/j.thromres.2023.10.001_bb0225","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2431-7-8","article-title":"A neonatal presentation of factor V deficiency: A case report","volume":"7","author":"Chingale","year":"2007","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.thromres.2023.10.001_bb0230","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/term.2785","article-title":"Packaging functionally important plasma proteins into the \u03b1-granules of human-induced pluripotent stem cell-derived megakaryocytes","volume":"13","author":"Zhang","year":"2019","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.thromres.2023.10.001_bb0235","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/MOH.0b013e3283497ebc","article-title":"A new look at blood coagulation factor V","volume":"18","author":"Camire","year":"2011","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0240","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.3390\/ijms24076243","article-title":"The Magic of Proteases: From a Procoagulant and Anticoagulant Factor V to an Equitable Treatment of Its Inherited Deficiency","volume":"24","author":"De Pablo-Moreno","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.thromres.2023.10.001_bb0245","author":"The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff (HGMD)"},{"key":"10.1016\/j.thromres.2023.10.001_bb0250","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0029-1225760","article-title":"Factor V Deficiency","volume":"35","author":"Asselta","year":"2009","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2023.10.001_bb0255","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0308-2261(18)30031-6","article-title":"Approaches to plasma fractionation for improved recovery and the development of potentially useful clinical factors","volume":"13","author":"Johnson","year":"1984","journal-title":"Clin. Haematol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0260","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.2020006315","article-title":"Emicizumab for the treatment of acquired hemophilia A","volume":"137","author":"Knoebl","year":"2021","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.10.001_bb0265","doi-asserted-by":"crossref","first-page":"723","DOI":"10.7326\/0003-4819-103-5-723","article-title":"The Acquired Immunodeficiency Syndrome in Persons with Hemophilia","volume":"103","author":"Levine","year":"1985","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2023.10.001_bb0270","first-page":"6","article-title":"The potential impact of recombinant factor VIII on hemophilia care and the demand for blood and blood products, Transfus","volume":"11","author":"VanAken","year":"1997","journal-title":"Med. Rev."},{"key":"10.1016\/j.thromres.2023.10.001_bb0275","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-7-24","article-title":"Past, present and future of hemophilia: a narrative review","volume":"7","author":"Franchini","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.thromres.2023.10.001_bb0280","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/j.1538-7836.2005.01367.x","article-title":"The promise and challenges of bioengineered recombinant clotting factors","volume":"3","author":"Pipe","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.001_bb0285","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.transci.2019.08.010","article-title":"The evolution of recombinant factor replacement for hemophilia","volume":"58","author":"Sankar","year":"2019","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.thromres.2023.10.001_bb0290","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1111\/hae.14313","article-title":"Comparative analysis of the pivotal studies of extended half-life recombinant FVIII products for treatment of haemophilia A","volume":"27","author":"Mannucci","year":"2021","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2023.10.001_bb0295","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/jth.14469","article-title":"Comparative pharmacokinetics of two extended half-life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?","volume":"17","author":"Carcao","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.001_bb0300","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/jth.12351","article-title":"Fresh frozen plasma: the most commonly prescribed hemostatic agent","volume":"11","author":"Puetz","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.001_bb0305","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4274\/tjh.galenos.2021.2021.0155","article-title":"Antithrombin, COVID-19, and Fresh Frozen Plasma Treatment","volume":"38","author":"Mungmunpuntipantip","year":"2021","journal-title":"Turk. J. Haematol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102771","article-title":"Methylene blue-treated plasma, versus quarantine fresh frozen plasma, for acute thrombotic thrombocytopenic purpura treatment: Comparison between centres and critical review on longitudinal data","volume":"59","author":"Arroyo","year":"2020","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.thromres.2023.10.001_bb0315","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1111\/hae.13895","article-title":"Novel treatment of combined factor V and factor VIII deficiency with Factor Eight Inhibitor Bypass Activity","volume":"26","author":"Olaiya","year":"2020","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2023.10.001_bb0320","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1423-0410.2009.01190.x","article-title":"Biochemical quality of the pharmaceutically licensed plasma OctaplasLG \u00ae after implementation of a novel prion protein (PrP Sc ) removal technology and reduction of the solvent\/detergent (S\/D) process time","volume":"97","author":"Heger","year":"2009","journal-title":"Vox Sang."},{"key":"10.1016\/j.thromres.2023.10.001_bb0325","first-page":"168","article-title":"\u2018Do not Do\u2019 Recommendations in Hemophilia, Cardiovasc. Hematol. Disord. Drug","volume":"20","author":"De la Corte-Rodriguez","year":"2020","journal-title":"Targets."},{"key":"10.1016\/j.thromres.2023.10.001_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104304","article-title":"An Engineered Factor Va Prevents Bleeding Induced by Anticoagulant wt Activated Protein C","volume":"9","author":"Von Drygalski","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2023.10.001_bb0335","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s11095-016-1895-3","article-title":"Safety, Stability and Pharmacokinetic Properties of (super)Factor Va, a Novel Engineered Coagulation Factor V for Treatment of Severe Bleeding","volume":"33","author":"Gale","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.thromres.2023.10.001_bb0340","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1706910","article-title":"Gene Therapy","volume":"381","author":"High","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2023.10.001_bb0345","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.omtn.2023.03.008","article-title":"In vivo genome editing for hemophilia B therapy by the combination of rebalancing and therapeutic gene knockin using a viral and non-viral vector","volume":"32","author":"Lee","year":"2023","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"10.1016\/j.thromres.2023.10.001_bb0350","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202115199","article-title":"Liver gene therapy with intein-mediated F8 trans-splicing corrects mouse haemophilia A","volume":"14","author":"Esposito","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.thromres.2023.10.001_bb0355","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.omtm.2021.07.006","article-title":"Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment","volume":"22","author":"Navarro","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.thromres.2023.10.001_bb0360","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/1566523220666200309125709","article-title":"Promising Gene Therapy Using an Adenovirus Vector Carrying REIC\/Dkk-3 Gene for the Treatment of Biliary Cancer","volume":"20","author":"Tanaka","year":"2020","journal-title":"Curr. Gene Ther."},{"issue":"2017","key":"10.1016\/j.thromres.2023.10.001_bb0365","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/cts.12466","article-title":"Progress and Future Directions","volume":"10","author":"Keeler","year":"2017","journal-title":"Clin. Transl .Sci."},{"key":"10.1016\/j.thromres.2023.10.001_bb0370","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMoa2113708","article-title":"Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A","volume":"386","author":"Ozelo","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2023.10.001_bb0375","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-Associated Virus (AAV) as a Vector for Gene Therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs."},{"issue":"2021","key":"10.1016\/j.thromres.2023.10.001_bb0380","first-page":"122","article-title":"In vivo lentiviral vector gene therapy for haemophilia","volume":"27","author":"Cantore","year":"2020","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2023.10.001_bb0385","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3390\/pharmaceutics15051453","article-title":"Emerging Roles of Mesenchymal Stem\/Stromal-Cell-Derived Extracellular Vesicles in Cancer Therapy","volume":"15","author":"Nicodemou","year":"2023","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.thromres.2023.10.001_bb0390","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.5966\/sctm.2014-0294","article-title":"Concise Review: Process Development Considerations for Cell Therapy: Process Development for Cell Therapy","volume":"4","author":"Campbell","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.thromres.2023.10.001_bb0395","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3390\/cells11030557","article-title":"Hematopoietic Cells from Pluripotent Stem Cells: Hope and Promise for the Treatment of Inherited Blood Disorders","volume":"11","author":"Rao","year":"2022","journal-title":"Cells."},{"key":"10.1016\/j.thromres.2023.10.001_bb0400","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12185-019-02765-0","article-title":"CRISPR\/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs","volume":"111","author":"Morishige","year":"2020","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0405","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.stemcr.2018.10.012","article-title":"Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A","volume":"11","author":"Olgasi","year":"2018","journal-title":"Stem Cell Reports."},{"key":"10.1016\/j.thromres.2023.10.001_bb0410","first-page":"ltac018","article-title":"Recent advances in immunotherapies against infectious diseases, Immunother","volume":"1","author":"Ramamurthy","year":"2020","journal-title":"Advanc."},{"key":"10.1016\/j.thromres.2023.10.001_bb0415","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1703068","article-title":"Emicizumab Prophylaxis in Hemophilia A with Inhibitors","volume":"377","author":"Oldenburg","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2023.10.001_bb0420","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.thromres.2023.10.001_bb0425","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13045-019-0817-3","article-title":"Delivery strategies of cancer immunotherapy: recent advances and future perspectives","volume":"12","author":"Zhao","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.742695","article-title":"Induction of Tolerance to Therapeutic Proteins With Antigen-Processing Independent T Cell Epitopes: Controlling Immune Responses to Biologics","volume":"12","author":"Schurgers","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0435","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.trsl.2017.06.002","article-title":"Hemophilia A inhibitor treatment: the promise of engineered T-cell therapy","volume":"187","author":"Parvathaneni","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.thromres.2023.10.001_bb0440","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1586\/ehm.10.33","article-title":"Immunomodulation for inhibitors in hemophilia A: the important role of Treg cells","volume":"3","author":"Miao","year":"2010","journal-title":"Expert. Rev. Hematol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0445","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2020.00476","article-title":"Escape or Fight: Inhibitors in Hemophilia A","volume":"11","author":"Merlin","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0450","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12325-008-0135-6","article-title":"Systematic review of efficacy of rFVIIa and aPCC treatment for hemophilia patients with inhibitors","volume":"26","author":"Knight","year":"2009","journal-title":"Adv. Therapy."},{"key":"10.1016\/j.thromres.2023.10.001_bb0455","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1182\/bloodadvances.2021006403","article-title":"Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A\/B with inhibitors","volume":"6","author":"Shapiro","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2023.10.001_bb0460","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/hae.14595","article-title":"Befovacimab, an anti-tissue factor pathway inhibitor antibody: Early termination of the multiple-dose, dose-escalating Phase 2 study due to thrombosis","volume":"28","author":"Mancuso","year":"2022","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2023.10.001_bb0465","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/bjh.18420","article-title":"A phase 1b\/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia","volume":"200","author":"Mahlangu","year":"2023","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0470","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1182\/blood-2019-122817","article-title":"Mim8 - a Next-Generation FVIII Mimetic Bi-Specific Antibody - Potently Restores the Hemostatic Capacity in Hemophilia a Settings in Vitro and In Vivo","volume":"134","author":"Kjellev","year":"2019","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.10.001_bb0475","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/S0140-6736(23)00514-7","article-title":"Fitusiran in haemophilia: a breakthrough drug with many unknowns","volume":"401","author":"Peyvandi","year":"2023","journal-title":"Lancet."},{"key":"10.1016\/j.thromres.2023.10.001_bb0480","doi-asserted-by":"crossref","first-page":"LBA-3","DOI":"10.1182\/blood-2021-155018","article-title":"Fitusiran, an Investigational siRNA Therapeutic Targeting Antithrombin for the Treatment of Hemophilia: First Results from a Phase 3 Study to Evaluate Efficacy and Safety in People with Hemophilia a or B without Inhibitors (ATLAS-A\/B)","volume":"138","author":"Srivastava","year":"2021","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.10.001_bb0485","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1182\/blood-2016-05-718635","article-title":"Design and characterization of an APC-specific serpin for the treatment of hemophilia","volume":"129","author":"Polderdijk","year":"2017","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.10.001_bb0490","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/jth.14610","article-title":"Engineering a protein Z-dependent protease inhibitor (ZPI) mutant as a novel antagonist of ZPI anticoagulant function for hemophilia treatment","volume":"17","author":"Huang","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.001_bb0495","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-0040-1716751","article-title":"Serpins, New Therapeutic Targets for Hemophilia","volume":"121","author":"Aymonnier","year":"2021","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.001_bb0500","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11248-017-0030-5","article-title":"Gene editing tools: state-of-the-art and the road ahead for the model and non-model fishes","volume":"26","author":"Barman","year":"2017","journal-title":"Transgenic Res."},{"key":"10.1016\/j.thromres.2023.10.001_bb0505","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/mt.2016.10","article-title":"Genome-editing Technologies for Gene and Cell Therapy","volume":"24","author":"Maeder","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.thromres.2023.10.001_bb0510","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1534\/genetics.111.131433","article-title":"Genome Engineering With Zinc-Finger Nucleases","volume":"188","author":"Carroll","year":"2011","journal-title":"Genetics."},{"key":"10.1016\/j.thromres.2023.10.001_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0243-1","article-title":"Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCs","volume":"51","author":"Sung","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.thromres.2023.10.001_bb0520","doi-asserted-by":"crossref","first-page":"9604","DOI":"10.3390\/ijms21249604","article-title":"Various Aspects of a Gene Editing System\u2014CRISPR\u2013Cas9","volume":"21","author":"Janik","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.thromres.2023.10.001_bb0525","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.tim.2016.06.005","article-title":"On the Origin of CRISPR-Cas Technology: From Prokaryotes to Mammals","volume":"24","author":"Mojica","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0530","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.834646","article-title":"Development and Application of CRISPR-Cas Based Tools","volume":"10","author":"Hu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0535","series-title":"CRISPR Gene Editing. Methods in Molecular Biology","first-page":"249","article-title":"F\u00fcchtbauer, Genome Editing in Mice","volume":"1961","author":"Hansen","year":"2019"},{"key":"10.1016\/j.thromres.2023.10.001_bb0540","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.3390\/ijms23095090","article-title":"Engineering CRISPR\/Cas9 for Multiplexed Recombinant Coagulation Factor Production","volume":"23","author":"Feser","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.thromres.2023.10.001_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2020.101948","article-title":"Generation of a gene edited hemophilia A patient-derived iPSC cell line, YCMi001-B-1, by targeted insertion of coagulation factor FVIII using CRISPR\/Cas9","volume":"48","author":"Sung","year":"2020","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.thromres.2023.10.001_bb0550","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.omtn.2018.12.008","article-title":"Viral Vector-Based Delivery of CRISPR\/Cas9 and Donor DNA for Homology-Directed Repair in an In Vitro Model for Canine Hemophilia B","volume":"14","author":"Gao","year":"2019","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"10.1016\/j.thromres.2023.10.001_bb0555","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.stem.2015.07.001","article-title":"Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9","volume":"17","author":"Park","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.thromres.2023.10.001_bb0560","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.tibtech.2016.02.011","article-title":"Genome Editing of Structural Variations: Modeling and Gene Correction","volume":"34","author":"Park","year":"2016","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0565","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/nprot.2016.129","article-title":"Modeling and correction of structural variations in patient-derived iPSCs using CRISPR\/Cas9","volume":"11","author":"Park","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.thromres.2023.10.001_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121429","article-title":"Therapeutic correction of hemophilia A using 2D endothelial cells and multicellular 3D organoids derived from CRISPR\/Cas9-engineered patient iPSCs","volume":"283","author":"Son","year":"2022","journal-title":"Biomaterials."},{"key":"10.1016\/j.thromres.2023.10.001_bb0575","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.stemcr.2019.04.016","article-title":"Universal Correction of Blood Coagulation Factor VIII in Patient-Derived Induced Pluripotent Stem Cells Using CRISPR\/Cas9","volume":"12","author":"Park","year":"2019","journal-title":"Stem Cell Reports."},{"key":"10.1016\/j.thromres.2023.10.001_bb0580","doi-asserted-by":"crossref","first-page":"1115831","DOI":"10.3389\/fgene.2023.1115831","article-title":"Correction of F8 intron 1 inversion in hemophilia A patient-specific iPSCs by CRISPR\/Cas9 mediated gene editing","volume":"14","author":"Hu","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.thromres.2023.10.001_bb0585","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.954984","article-title":"Comparison of different gene addition strategies to modify placental derived-mesenchymal stromal cells to produce FVIII","volume":"13","author":"Ramamurthy","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0590","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.omtn.2019.05.019","article-title":"ssODN-Mediated In-Frame Deletion with CRISPR\/Cas9 Restores FVIII Function in Hemophilia A-Patient-Derived iPSCs and ECs","volume":"17","author":"Hu","year":"2019","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"10.1016\/j.thromres.2023.10.001_bb0595","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.672564","article-title":"CRISPR\/Cas9-Mediated in vivo Genetic Correction in a Mouse Model of Hemophilia A","volume":"9","author":"Luo","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0600","doi-asserted-by":"crossref","first-page":"16838","DOI":"10.1038\/s41598-019-53198-y","article-title":"Hemophilia A ameliorated in mice by CRISPR-based in vivo genome editing of human Factor VIII","volume":"9","author":"Chen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2023.10.001_bb0605","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13059-019-1907-9","article-title":"Curing hemophilia A by NHEJ-mediated ectopic F8 insertion in the mouse","volume":"20","author":"Zhang","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0610","first-page":"704","article-title":"Novel Severe Hemophilia A Mouse Model with Factor VIII Intron 22 Inversion","volume":"10","author":"Han","year":"2021","journal-title":"Biology (Basel)."},{"key":"10.1016\/j.thromres.2023.10.001_bb0615","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1182\/bloodadvances.2019000944","article-title":"The severe spontaneous bleeding phenotype in a novel hemophilia A rat model is rescued by platelet FVIII expression","volume":"4","author":"Shi","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2023.10.001_bb0620","doi-asserted-by":"crossref","first-page":"135","DOI":"10.24920\/J1001-9294.2017.032","article-title":"Genetic Correction and Hepatic Differentiation of Hemophilia B-specific Human Induced Plutipotent Stem Cells","volume":"32","author":"He","year":"2017","journal-title":"Chin. Med. Sci. J."},{"key":"10.1016\/j.thromres.2023.10.001_bb0625","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.3390\/ijms24109013","article-title":"CRISPR-Mediated In Situ Introduction or Integration of F9-Padua in Human iPSCs for Gene Therapy of Hemophilia B","volume":"24","author":"Tang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.thromres.2023.10.001_bb0630","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13287-022-03036-2","article-title":"Generation of an mESC model with a human hemophilia B nonsense mutation via CRISPR\/Cas9 technology","volume":"13","author":"Ma","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.thromres.2023.10.001_bb0635","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.3390\/ijms19103035","article-title":"Paired CRISPR\/Cas9 Nickases Mediate Efficient Site-Specific Integration of F9 into rDNA Locus of Mouse ESCs","volume":"19","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.thromres.2023.10.001_bb0640","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3020","article-title":"Designer nuclease-mediated gene correction via homology-directed repair in an in vitro model of canine hemophilia B","volume":"20","author":"Bergmann","year":"2018","journal-title":"J. Gene Med."},{"key":"10.1016\/j.thromres.2023.10.001_bb0645","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jgg.2022.06.001","article-title":"Long-term correction of hemophilia B through CRISPR\/Cas9 induced homology-independent targeted integration","volume":"49","author":"Chen","year":"2022","journal-title":"J. Genet. Genomics."},{"key":"10.1016\/j.thromres.2023.10.001_bb0650","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood.2019000790","article-title":"CRISPR\/Cas9-mediated in vivo gene targeting corrects hemostasis in newborn and adult factor IX\u2013knockout mice","volume":"133","author":"Wang","year":"2019","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.10.001_bb0655","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/hep.32211","article-title":"In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model","volume":"75","author":"Luce","year":"2022","journal-title":"Hepatology."},{"key":"10.1016\/j.thromres.2023.10.001_bb0660","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1038\/s41598-017-04625-5","article-title":"CRISPR\/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice","volume":"7","author":"Ohmori","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2023.10.001_bb0665","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13287-018-0839-8","article-title":"Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system","volume":"9","author":"Lyu","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.thromres.2023.10.001_bb0670","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.omtm.2020.06.025","article-title":"CRISPR-Cas9-Mediated In Vivo Gene Integration at the Albumin Locus Recovers Hemostasis in Neonatal and Adult Hemophilia B Mice","volume":"18","author":"Wang","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.thromres.2023.10.001_bb0675","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.1038\/s41467-022-34898-y","article-title":"Low-dose AAV-CRISPR-mediated liver-specific knock-in restored hemostasis in neonatal hemophilia B mice with subtle antibody response","volume":"13","author":"He","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.thromres.2023.10.001_bb0680","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2022.785698","article-title":"Promoterless Gene Targeting Approach Combined to CRISPR\/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal Mice","volume":"4","author":"Lisjak","year":"2022","journal-title":"Front. Genome Ed."},{"key":"10.1016\/j.thromres.2023.10.001_bb0685","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2019.02.009","article-title":"Long-term correction of hemophilia B using adenoviral delivery of CRISPR\/Cas9","volume":"298","author":"Stephens","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.thromres.2023.10.001_bb0690","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00439-017-1801-z","article-title":"CRISPR\/Cas9-mediated somatic and germline gene correction to restore hemostasis in hemophilia B mice","volume":"136","author":"Huai","year":"2017","journal-title":"Hum. Genet."},{"key":"10.1016\/j.thromres.2023.10.001_bb0695","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbrc.2022.08.076","article-title":"Delivery of Cas9-guided ABE8e into stem cells using poly(l-lysine) polypeptides for correction of the hemophilia-associated FIX missense mutation","volume":"628","author":"Rong","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.thromres.2023.10.001_bb0700","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s43856-023-00286-w","article-title":"PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells","volume":"3","author":"Hiramoto","year":"2023","journal-title":"Commun. Med."},{"key":"10.1016\/j.thromres.2023.10.001_bb0705","unstructured":"Q. Wang, C. Huai, R. Sun, H. Zhuang, H. Chen, J. Fei, D. Lu, A quick and efficient method to generate hemophilia B mouse models by the CRISPR\/Cas system. Hereditas (Beijing). 37. 1143-1148. doi:10.16288\/j.yczz.15-117."},{"key":"10.1016\/j.thromres.2023.10.001_bb0710","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3324\/haematol.2019.224063","article-title":"CRISPR\/Cas9-mediated knockin of human factor IX into swine factor IX locus effectively alleviates bleeding in hemophilia B pigs","volume":"106","author":"Chen","year":"2020","journal-title":"Haematol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0715","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1111\/jth.15897","article-title":"Comparative sequence analysis of vitamin K-dependent coagulation factors","volume":"20","author":"Stojanovski","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.001_bb0720","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1182\/blood-2015-10-677633","article-title":"Characterization of vitamin K\u2013dependent carboxylase mutations that cause bleeding and nonbleeding disorders","volume":"127","author":"Tie","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.10.001_bb0725","first-page":"811","article-title":"Development of a cell-based diagnostic system for vitamin K-dependent coagulation factor deficiency 1","volume":"37","author":"Gao","year":"2020","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi."},{"key":"10.1016\/j.thromres.2023.10.001_bb0730","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/jth.14456","article-title":"Exon 2 skipping eliminates \u03b3-glutamyl carboxylase activity, indicating a partial splicing defect in a patient with vitamin K clotting factor deficiency","volume":"17","author":"Rishavy","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.001_bb0735","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1182\/bloodadvances.2017006775","article-title":"VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites","volume":"2","author":"Czogalla","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2023.10.001_bb0740","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1182\/blood-2017-04-780379","article-title":"Human NOTCH4 is a key target of RUNX1 in megakaryocytic differentiation","volume":"131","author":"Li","year":"2018","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.10.001_bb0745","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/ATVBAHA.116.308614","article-title":"Novel Thrombotic Function of a Human SNP in STXBP5 Revealed by CRISPR\/Cas9 Gene Editing in Mice","volume":"37","author":"Zhu","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0750","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1111\/jgh.14666","article-title":"Establishment of gene-edited pigs expressing human blood-coagulation factor VII and albumin for bioartificial liver use","volume":"34","author":"Li","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.thromres.2023.10.001_bb0755","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/genes11060713","article-title":"Evaluation of the CRISPR\/Cas9 Genetic Constructs in Efficient Disruption of Porcine Genes for Xenotransplantation Purposes Along with an Assessment of the Off-Target Mutation Formation","volume":"11","author":"Ryczek","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.thromres.2023.10.001_bb0760","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbrc.2018.05.136","article-title":"Tissue factor mediates microvesicles shedding from MDA-MB-231 breast cancer cells","volume":"502","author":"Rondon","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.thromres.2023.10.001_bb0765","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1172\/JCI133780","article-title":"A coagulation defect arising from heterozygous premature termination of tissue factor","volume":"130","author":"Schulman","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2023.10.001_bb0770","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1055\/a-1723-4075","article-title":"Knockdown and Knockout of Tissue Factor Pathway Inhibitor in Zebrafish","volume":"122","author":"Raman","year":"2022","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.001_bb0775","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006981","article-title":"An ADAM-10 dependent EPCR shedding links meningococcal interaction with endothelial cells to purpura fulminans","volume":"14","author":"L\u00e9cuyer","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.thromres.2023.10.001_bb0780","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022248118","article-title":"Thrombomodulin is essential for maintaining quiescence in vascular endothelial cells","volume":"118","author":"Giri","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.thromres.2023.10.001_bb0785","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1111\/febs.14153","article-title":"Biochemical characterization of a medaka (Oryzias latipes) orthologue for mammalian Factor XIII and establishment of a gene-edited mutant","volume":"284","author":"Horimizu","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.thromres.2023.10.001_bb0790","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/hae.14104","article-title":"Successful correction of factor V deficiency of patient-derived iPSCs by CRISPR\/Cas9-mediated gene editing","volume":"26","author":"Nakamura","year":"2020","journal-title":"Haemophilia."},{"key":"10.1016\/j.thromres.2023.10.001_bb0795","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/384066a0","article-title":"Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V","volume":"384","author":"Cui","year":"1996","journal-title":"Nature."},{"key":"10.1016\/j.thromres.2023.10.001_bb0800","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/bloodadvances.2018029066","article-title":"Analysis of factor V in zebrafish demonstrates minimal levels needed for early hemostasis","volume":"3","author":"Weyand","year":"2019","journal-title":"Blood Adv."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823002785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823002785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:51:59Z","timestamp":1758736319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823002785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":160,"alternative-id":["S0049384823002785"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.10.001","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of congenital coagulopathies, from biologic to biotechnological drugs: The relevance of gene editing (CRISPR\/Cas)","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}